HEALTH CHECK
16/05/24 -"As we have consistently argued over the last 3 years, Health stocks (ex Pharma) are long on growth promises and short on delivery. The gap stems from the fact that delivery hinges on buying the next ..."
Pages
46
Language
English
Published on
16/05/24
You may also be interested by these reports :
02/09/26
Swiss Life reported 1H26 results, which were broadly in line with our estimates and slightly above consensus. The segment result included both ...
28/08/26
Ageas reported good 1H26 results, with strong inflows, particularly in Life in Europe, and an increase in the net operating result despite ...
27/08/26
EssilorLuxottica (EL) (BUY; France) share price peaked in late 2025 and has shed 40% ytd. No small feat for a stock that used to be worth more than ...
24/08/26
The 1H26 results were strong across the reinsurance sector. At the half-year stage, the FY targets generally looked as secure. However, restated for ...